Homecare Delivery Service - Lysosomol Storage Disorder

NHS England is planning a public procurement process for the "Homecare Delivery Service - Lysosomol Storage Disorder" across the UK. Categorised under home medical treatment services, this tender is in the planning stage, with the procurement notice having been published on 21st May 2025. The contract is planned to start on 1st July 2027 and end by 30th June 2029, with potential renewal extending it to 2031.

Located in London, the opportunity is structured as a national framework agreement with key communications expected by the start of 2026. The total value of the procurement is £14,936,000, with a gross amount of £17,923,200. This procurement presents significant opportunities for businesses involved in home medical treatment services, particularly small and medium-sized enterprises (SMEs), as indicated by the suitability criteria.

Companies specialising in or looking to expand into the delivery of specialised healthcare services can benefit from engaging with NHS England. The scale and duration of the contract provide a stable business growth avenue, making it well-suited for businesses capable of meeting long-term service commitments. Additionally, the national reach and central government backing underscore the strategic value and reliability of participating in this tender process.